Bioalpha Holdings Bhd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bioalpha Holdings Bhd with three other
pharmaceutical manufacturers in Asia:
Star Pharmaceutical Limited
sales of 93.32 million Chinese Renmimbi [US$14.66 million]
Ngl Fine Chem Ltd
(1.00 billion Indian Rupees [US$14.72 million]
Traphaco High Tech Joint Stock Co
based in Vietnam
(318.19 billion Dong [US$13.97 million]
Bioalpha Holdings Bhd reported sales of 55.92 million Malaysian Ringgits (US$14.10 million)
December of 2017.
increase of 18.7%
versus 2016, when the company's sales were 47.12 million Malaysian Ringgits.
Sales at Bioalpha Holdings Bhd have increased during each of the previous five years
(and since 2012, sales have increased a total of 193%).